ASSESSING THE PERCENT OF DAYS LINACLOTIDE IMPROVED ABDOMINAL SYMPTOMS AND STOOL FREQUENCY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): POOLED ANALYSIS OF 2 PHASE 3 TRIALS

被引:0
|
作者
Rao, S. S. [1 ]
Chang, L. [2 ]
Hao, X. [3 ]
Lavins, B. [3 ]
Shiff, S. J. [4 ]
Cao, X. [4 ]
Schneier, H. [4 ]
Currie, M. [3 ]
Johnston, J. [3 ]
机构
[1] Georgia Hlth Sci Univ, Augusta, GA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Ironwood Pharmaceut, Cambridge, MA USA
[4] Forest Res Inst, Jersey City, NJ USA
关键词
D O I
10.1136/gutjnl-2013-304907.314
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A139 / A140
页数:2
相关论文
共 50 条
  • [1] Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients With IBS-C: A Pooled Analysis of Two Phase 3 Trials
    Rao, Satish S.
    Chang, Lin
    Hao, Xinming
    Lavins, Bernard J.
    Shiff, Steven J.
    Cao, Xiaofan
    Schneier, Harvey
    Currie, Mark G.
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2012, 142 (05) : S816 - S817
  • [2] Assessing percent days linaclotide improved abdominal symptoms and stool frequency in IBS-C patients
    Johnston, Jeffrey M.
    Rao, Satish S.
    Chang, Lin
    Hao, Xinming
    Lavins, Bernard J.
    Shiff, Steven J.
    Cao, Xiaofan
    Currie, Mark G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 354 - 355
  • [3] A pooled analysis of two phase 3 trials assessing the percentage of days linaclotide improved abdominal symptoms and stool frequency in patients with IBS-C
    Rao, S.
    Chang, L.
    Hao, X.
    Lavins, B.
    Shiff, S.
    Cao, X.
    Schneier, H.
    Currie, M.
    Johnston, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 107 - 108
  • [4] Improvement in abdominal symptoms rated as most severe by patients with Irritable Bowel Syndrome with Constipation (IBS-C): Results from two phase 3 trials of linaclotide
    Rao, S.
    Quigley, E.
    Shiff, S.
    Lavins, B.
    Kurtz, C.
    Schneier, H.
    Currie, M.
    Johnston, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 27 - 27
  • [5] SIGNIFICANT IMPROVEMENTS IN ABDOMINAL PAIN AND BOWEL SYMPTOMS IN A PHASE 3 TRIAL OF LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C): A EUROPEAN PERSPECTIVE
    Quigley, E. M.
    Lembo, A. J.
    Diaz, C.
    Fortea, J.
    Falques, M.
    Shiff, S.
    Shi, K.
    Schneier, H. A.
    Johnston, J. M.
    GUT, 2012, 61 : A247 - A248
  • [6] Efficacy of Linaclotide in Improving Abdominal Symptoms Rated as Most Severe by Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
    Rao, Satish S.
    Quigley, Eamonn M.
    Shiff, Steven J.
    Lavins, Bernard J.
    Kurtz, Caroline B.
    MacDougall, James E.
    Shi, Kelvin
    Schneier, Harvey
    Currie, Mark G.
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2012, 142 (05) : S144 - S144
  • [7] A pooled analysis of two phase 3 trials to determine the effects of linaclotide treatment on patient-reported ratings of change for symptoms of Irritable Bowel Syndrome with Constipation (IBS-C)
    Locke, G.
    Chey, W.
    Kurtz, C.
    Carson, R.
    Baird, M.
    Currie, M.
    Schneier, H.
    John-Ston, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 105 - 106
  • [8] Effects of Linaclotide on Straining Associated With Bowel Movements in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A Post Hoc Analysis of Pooled Data From Two Phase 3 Trials
    Lembo, Anthony
    Rao, Satish S.
    Shiff, Steven J.
    Lavins, Bernard J.
    MacDougall, James E.
    Shi, Kelvin
    Schneier, Harvey
    Currie, Mark G.
    Johnston, Jeffrey M.
    GASTROENTEROLOGY, 2012, 142 (05) : S828 - S829
  • [9] Effects of linaclotide on abdominal and bowel symptoms over the first seven days of treatment in patients with Irritable Bowel Syndrome (IBS) with constipation
    Chang, L.
    Lembo, A.
    Shiff, S.
    Shao, J.
    Lavins, B.
    Shi, K.
    Schneier, H.
    Currie, M.
    Johnston, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 105 - 105
  • [10] Bloating is more strongly associated with abdominal pain than with stool frequency in irritable bowel syndrome with constipation (IBS-C)
    Earnest, D
    Dunger-Baldauf, C
    Shetzline, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S343 - S343